ESC TV Today – Your Cardiovascular News copertina

ESC TV Today – Your Cardiovascular News

ESC TV Today – Your Cardiovascular News

Di: European Society of Cardiology
Ascolta gratuitamente

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and HFA Cardio Talk. Check them out!The entire contents of these podcasts are subject to ESC copyright (all rights reserved). Disturbo fisico e malattia Igiene e vita sana
  • Season 4 - Ep1: Extended interview on Digital solutions in arrhythmias
    Jan 22 2026

    Host: Emer Joyce

    Guest: Fleur Tjong

    Want to watch that extended interview on https://esc365.escardio.org/event/2528?resource=interview

    Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2528

    Disclaimer:

    ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    All declarations of interest are listed at the end of the episode.

    The ESC is not liable for any translated content of this video. The English language always prevails.

    Declarations of interests:

    Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.

    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Fleur Tjong has declared to have potential conflicts of interest to report: Amsterdam UMC Innovation grant, Heath Holland TKI, Abbott, Dutch Research Council, Boston Scientific.

    Mostra di più Mostra meno
    10 min
  • Season 4 - Ep1: What´s new in TAVI? - Digital solutions in arrhythmias
    Jan 22 2026

    This episode covers:

    • Cardiology This Week: A concise summary of recent studies
    • What´s new in TAVI?
    • Digital solutions in arrhythmias
    • Mythbusters - Gratitude is heart healthy

    Host: Emer Joyce

    Guests: JP Carpenter, Davide Capodanno, Fleur Tjong

    Want to watch that episode? Go to: https://esc365.escardio.org/event/2528

    Want to watch that extended interview on Digital solutions in arrhythmias, go to: https://esc365.escardio.org/event/2528?resource=interview

    Disclaimer:

    ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    All declarations of interest are listed at the end of the episode.

    The ESC is not liable for any translated content of this video. The English language always prevails.

    Declarations of interests:

    Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.

    Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Fleur Tjong has declared to have potential conflicts of interest to report: Amsterdam UMC Innovation grant, Heath Holland TKI, Abbott, Dutch Research Council, Boston Scientific.

    Mostra di più Mostra meno
    24 min
  • Season 3 - Ep.28: Extended interview on dual antiplatelet therapy (DAPT) and shortening its optimal duration
    Dec 4 2025

    Host: Emer Joyce

    Guest: Steffen Massberg

    Want to watch that extended interview on https://esc365.escardio.org/event/2178?resource=interview

    Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2178

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

    The programme has not been influenced in any way by its funding partners.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    The ESC is not liable for any translated content of this video.

    The English language always prevails.

    Declarations of interests

    Emer Joyce and Steffen Massberg have declared to have no potential conflicts of interest to report.

    Mostra di più Mostra meno
    10 min
Ancora nessuna recensione